Abbott’s ABT diversified business portfolio is well-positioned to drive continued momentum in 2025. Yet, the international business environment continues to be challenging globally. The stock carries ...

Mary Cunningham is a reporter for CBS MoneyWatch. Before joining the business and finance vertical, she worked at "60 Minutes," CBSNews.com and CBS News 24/7 as part of the CBS News Associate Program.

The device, called Biolinq Shine, is indicated for people with Type 2 diabetes who don’t depend on insulin.

Currently priced at $2,829 (discounted from its $3,550 MSRP), the Beatbot AquaSense 2 Ultra is around $1200 more than the comparable Aiper Scuba X1 Pro Max I reviewed a three months ago, and almost ...